SaneVax, Inc.

The First International HPV Vaccine Information Clearinghouse

Immune and Genetic Susceptibility in the Development of Cervical Cancer

By

Authors:  Barbara Mora, Felipe M. Benavente,  Carmen G. Ili, and Pricilla Brebi Abstract:  Cervical cancer is the second most frequent cancer in women worldwide. Although 99.7% of cases are attributed to a previous infection by Human papillomavirus, a small percentage of the infected women progress to cervical cancer, suggesting the existence of different risk factors […]

[Continue reading...]

HPV: Non-sexual means of transmission

By

Non sexual means Abstract Aim: There is strong evidence to suggest vertical and horizontal modes of transmission of human papilloma virus (HPV), an established etiologic agent of cervical cancer. Infants, children, and adults can acquire both high-risk and low-risk infections by birth or by close contact even though HPV is mainly transmitted sexually. A thorough […]

[Continue reading...]

Immunological studies of cerebrospinal fluid from patients with CNS symptoms after human papillomavirus vaccination

By 4 Comments

Immunological studies of cerebrospinal fluid from patients with CNS symptoms after human papillomavirus vaccination Highlights •32 patients with prolonged CNS symptoms after HPV vaccination were studied. •CSF levels of IL-4, IL-13, IL-17, IL-8 and MCP-1 were elevated. •CSF levels of PDGF-bb and IL-12 were decreased. •Antibodies to GluN2B-NT2, GluN2B-CT and GluN1-NT in CSF were increased. […]

[Continue reading...]

Prevalence of type-specific HPV among female university students from northern Brazil

By

Authors: Rodrigo Covre Vieira1*, Jeniffer do Socorro Valente Monteiro2, Estéfane Primo Manso2, Maria Renata Mendonça dos Santos3, Mihoko Yamamoto Tsutsumi4, Edna Aoba Yassui Ishikawa1, Stephen Francis Ferrari5,Karla Valéria Batista Lima6 and Maísa Silva de Sousa1 Abstract Background Human papillomavirus (HPV) infection is associated with cervical cancer, the most frequent cancer in women from northern Brazil. Assessment […]

[Continue reading...]

Vitamin D Levels, Antibody Titers Produced in Response

By

Do Vitamin D Levels Affect Antibody Titers Produced in Response to HPV Vaccine? Antibody Titers Produced in Response Authors: Zimmerman RK1, Lin CJ, Raviotta JM, Nowalk MP. Abstract In addition to its well-known effects on bone metabolism, vitamin D is an immunomodulating hormone. Serum vitamin D levels in males 18-25 years were measured at baseline, and HPV […]

[Continue reading...]

High prevalence of hpv multiple genotypes in women with persistent chlamydia trachomatis infection

By Leave a Comment

Silva Seraceni1†, Francesco De Seta12, Claudia Colli3, Rossella Del Savio1, Giuliano Pesel1, Valentina Zanin1, Pierlanfranco D’Agaro12,Carlo Contini4 and Manola Comar12*† Abstract Background Chlamydia trachomatis interaction with HR-HPV types has highlighted a central role in cervical cancer development. The aim of this study was to investigate HPV prevalence and genotypes distribution in women at risk for […]

[Continue reading...]

Is human papillomavirus vaccination likely to be a useful strategy in India?

By Leave a Comment

India …Strategy in India  Sudeep Gupta, Rajendra A. Kerkar,1 Rajesh Dikshit,2 and Rajendra A. Badwe1 Author information ► Copyright and License information ►   .. Abstract Two vaccines that protect against infection by some of the oncogenic human papillomavirus (HPV) subtypes have recently been licensed for use in population-based vaccination strategies in many countries. However, these products are being promoted as ‘cervical cancer […]

[Continue reading...]

Prevalence and type distribution of high-risk human papillomavirus in patients with cervical cancer: a population-based study

By Leave a Comment

Prevalence Mohammadreza Haghshenas1, Tahereh Golini-moghaddam2, Alireza Rafiei1, Omid Emadeian2, Ahmad Shykhpour1 and G Hossein Ashrafi3* Abstract Background Cervical cancer is the greater cause of cancer death in women in many developing countries. Persistent infection with human papilloma virus (HPV), primarily high risk types 16 and 18, is recognized as a causal and essential factor for the development of cervical cancer. We […]

[Continue reading...]

NATURAL HEALTH: Is HPV worse than vaccine?

By Leave a Comment

By Catherine Stack, Niagara Gazette NIAGARA FALLS — A few years back I wrote an article that questioned the effectiveness and potentially exposed some risks associated with the Swine flu vaccine. I was slammed with both positive and negative emails. I am now about to raise some concerns about another vaccine in hopes of educating […]

[Continue reading...]

Human papillomavirus DNA detected in peripheral blood samples from healthy Australian male blood donors

By Leave a Comment

J Med Virol. 2009 Oct;81(10):1792-6 Chen AC, Keleher A, Kedda MA, Spurdle AB, McMillan NA, Antonsson A. The University of Queensland, Diamantina Institute for Cancer, Immunology and Metabolic Medicine, Princess Alexandra Hospital, Woolloongabba, Brisbane, QLD, Australia. Abstract Recent studies have shown that human papillomavirus (HPV) DNA can be found in circulating blood, including peripheral blood mononuclear cells (PBMCs), sera, plasma, and […]

[Continue reading...]

Could Human Papillomaviruses Be Spread through Blood?

By Leave a Comment

J Clin Microbiol. 2005 November; 43(11): 5428–5434 doi: 10.1128/JCM.43.11.5428-5434.2005 Sohrab Bodaghi,1 Lauren V. Wood,1 Gregg Roby,1 Celia Ryder,1 Seth M. Steinberg,2 and Zhi-Ming Zheng1* HIV and AIDS Malignancy Branch,1 Biostatistics and Data Management Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland2 *Corresponding author. Mailing address: HIV and AIDS Malignancy Branch, Center for Cancer Research, NCI/NIH, […]

[Continue reading...]

Human Papilloma Virus: The First Cancer Vaccine

By 1 Comment

Posted on The Doctor Within It was inevitable. In the post 9/11 marketing frenzy questing for more and more bugs and diseases to make vaccines against, what could be a more promising candidate than the second highest cause of death in the US? Cancer of the cervix has been on a gradual upswing during the […]

[Continue reading...]

The pathogenesis of Human Papillomavirus (HPV) in the development of cervical cancer: are HPV vaccines a safe and effective management strategy?

By Leave a Comment

By Judy Wilyman, MSc Abstract Human Papillomavirus (HPV) infection has been linked with cervical cancer. Some medical professionals see it as the determining causal agent and therefore promote vaccination as an effective prevention strategy. However, the biological plausibility of a causal theory requires that the incidence of the causal agent varies with the incidence and […]

[Continue reading...]

THE HPV VACCINE MYSTERIES – MUST READ

By Leave a Comment

By Janine Roberts WHY IS A NOBEL AWARD BEING GIVEN FOR THIS ON DECEMBER 10TH? There are two licensed HPV vaccines in the world. Merck makes Gardasil. It contains proteins said to come originally from four different types of HPV. By early 2008 over 10 million doses had been distributed, three-quarters of these in the USA. It […]

[Continue reading...]

SANE Vax to NCI/FDA: Request for reliable HPV genotyping test for medical consumers

By Leave a Comment

November 2, 2010 The Honorable Margaret Hamburg, M.D., Commissioner, FDA The Honorable Harold E. Varmus, M.D., Director,NCI  Subject: Request recommending a reliable human papillomavirus (HPV) genotyping test to support the national virology-based cervical cancer prevention program for patient care Dear Dr. Hamburg and Dr. Varmus: A recently published letter to the editor of ‘Obstetrics and […]

[Continue reading...]

Cigarette smoking and human papillomavirus in patients with reported cervical cytological abnormality.

By Leave a Comment

Pubmed
BMJ. 1993 Mar 20;306(6880):749-52.

Burger MP, Hollema H, Gouw AS, Pieters WJ, Quint WG.

Department of Obstetrics and Gynaecology, University Hospital, Groningen, Netherlands.

Comment in:

BMJ. 1993 May 8;306(6887):1269.
BMJ. 1993 May 8;306(6887):1269.
BMJ. 1993 May 8;306(6887):1268-9.

Abstract
OBJECTIVE: To assess the relation between two risk factors for cervical neoplasia: smoking and infection with oncogenic human papillomavirus. It has been suggested that smoking causes a local immunological defect, which could facilitate the infection and persistence of human papillomavirus.

DESIGN: Cross sectional epidemiological study. Completion of a structured questionnaire by the patients, analysis of cervical scrapes for human papillomavirus, and morphological examination of biopsy specimens.

SETTING: Outpatient gynaecological clinic.

SUBJECTS: 181 women with a report of cervical cytological abnormality.

MAIN OUTCOME MEASURES: Prevalence of infection with oncogenic human papillomavirus and smoking habits.

[Continue reading...]

News

Videos

Contact